Shonan Sho
Overview
Explore the profile of Shonan Sho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
458
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sho S, Yothers G, Colangelo L, Ganz P, OConnell M, Beart Jr R, et al.
Dis Colon Rectum
. 2020 Jul;
63(8):1063-1070.
PMID: 32692071
Background: Accurate and comprehensive surgical pathology reports are integral to the quality of cancer care. Despite guidelines from the College of American Pathologists, variations in reporting quality continue to exist....
2.
Sho S, Dawes A, Chen F, Russell M, Kwaan M
Dis Colon Rectum
. 2020 Apr;
63(8):1127-1133.
PMID: 32251145
Background: Perirectal abscess is a common problem. Despite a seemingly simple disease to manage, clinical outcomes of perirectal abscesses can vary significantly given the wide array of patients who are...
3.
4.
Sho S, Kuo E, Chen A, Li N, Yeh M, Livhits M
Ann Surg Oncol
. 2018 Nov;
26(2):539-546.
PMID: 30406488
Background: Normocalcemic (incipient) primary hyperparathyroidism (PHPT) is characterized by inappropriately elevated parathyroid hormone (PTH) levels in the setting of normal serum calcium. The biochemical and skeletal outcomes after parathyroidectomy for...
5.
Sho S, Court C, Winograd P, Toste P, Pisegna J, Lewis M, et al.
J Gastrointest Surg
. 2018 Oct;
23(7):1392-1400.
PMID: 30353489
Background: Patients with early-stage pancreatic neuroendocrine tumors (PNETs) may develop metastatic recurrences despite undergoing potentially curative pancreas resections. We sought to identify factors predictive of metastatic recurrences and develop a...
6.
Court C, Hou S, Winograd P, Segel N, Li Q, Zhu Y, et al.
Liver Transpl
. 2018 Apr;
24(7):946-960.
PMID: 29624843
Current clinicopathologic staging systems and serum biomarkers poorly discriminate tumor biology in hepatocellular carcinoma (HCC), with high recurrence rates following curative-intent surgical resection and liver transplantation (LT). Identification of accurate...
7.
Court C, Ankeny J, Sho S, Winograd P, Hou S, Song M, et al.
Ann Surg Oncol
. 2018 Feb;
25(4):1000-1008.
PMID: 29442211
Background: Occult metastatic tumors, below imaging thresholds, are a limitation of staging systems that rely on cross-sectional imaging alone and are a cause of the routine understaging of pancreatic ductal...
8.
9.
Court C, Ankeny J, Sho S, Tomlinson J
Cancer Treat Res
. 2017 Dec;
168:345-76.
PMID: 29206383
GI cancers are the leading cause of cancer-related death worldwide primarily due to a combination of late presentation and aggressive biology. The lack of adequate biomarkers for screening, diagnosis, staging,...
10.
Kuo E, Sho S, Li N, Zanocco K, Yeh M, Livhits M
JAMA Surg
. 2017 Oct;
153(1):52-59.
PMID: 28973144
Importance: The association of initial neck dissection with recurrence in medullary thyroid carcinoma (MTC) has not been evaluated on a population level to date. Objective: To elucidate risk factors associated...